Mascoma Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12K Sell
13
-4
-24% -$353 ﹤0.01% 491
2026
Q2
$1.33K Buy
+17
New +$1.37K ﹤0.01% 484
2026
Q1
– Sell
-16
Closed -$1.54K – 531
2025
Q4
$1.54K Buy
+16
New +$1.55K ﹤0.01% 427
2025
Q1
– Sell
-37
Closed -$2.96K – 521
2024
Q4
$2.96K Buy
+37
New +$3.2K ﹤0.01% 450
2024
Q3
– Sell
-110
Closed -$8.66K – 476
2024
Q2
$8.66K Hold
110
– – ﹤0.01% 350
2024
Q1
$9.6K Hold
110
– – ﹤0.01% 317
2023
Q4
$9.06K Sell
110
-110
-50% -$8.38K ﹤0.01% 325
2023
Q3
$17.2K Hold
220
– – 0.01% 285
2023
Q2
$18.1K Sell
220
-92
-29% -$7.92K 0.01% 275
2023
Q1
$28.4K Hold
312
– – 0.01% 299
2022
Q4
$24.2K Sell
312
-50
-14% -$4.05K 0.01% 312
2022
Q3
$29K Sell
362
-24
-6% -$2.16K 0.01% 294
2022
Q2
$35K Sell
386
-8
-2% -$811 0.01% 287
2022
Q1
$44K Buy
394
+116
+42% +$12.3K 0.01% 278
2021
Q4
$29K Buy
278
+8
+3% +$926 0.01% 282
2021
Q3
$34K Buy
+270
New +$34.9K 0.01% 240
2021
Q2
– Sell
-270
Closed -$32K – 314
2021
Q1
$32K Buy
+270
New +$31.6K 0.01% 254
2019
Q1
– Sell
-130
Closed -$12K – 407
2018
Q4
$12K Sell
130
-143
-52% -$13.4K 0.01% 247
2018
Q3
$27K Hold
273
– – 0.02% 211
2018
Q2
$23K Hold
273
– – 0.02% 213
2018
Q1
$22K Hold
273
– – 0.01% 214
2017
Q4
$23K Buy
273
+40
+17% +$3.2K 0.01% 204
2017
Q3
$18K Hold
233
– – 0.01% 240
2017
Q2
$21K Sell
233
-600
-72% -$50.6K 0.01% 234
2017
Q1
$67K Hold
833
– – 0.05% 126
2016
Q4
$59K Buy
+833
New +$65.4K 0.04% 133

Other funds holding MDT

Mascoma Wealth Management's MDT Position: Q3 2026 in Review

Mascoma Wealth Management reduced its Medtronic (MDT) stake by 24% in Q3 2026, selling an estimated $353 and leaving 13 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #491.

Mascoma Wealth Management first reported a position in MDT in Q4 2016 and has held it in 26 quarters since. The position peaked at $67K in Q1 2017. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Mascoma Wealth Management held 13 shares of Medtronic worth $1.12K as of Q3 2026.
  • Mascoma Wealth Management sold 4 Medtronic shares in Q3 2026, an estimated $353.
  • Medtronic made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q3 2026, its #491 holding.
  • Mascoma Wealth Management first reported a position in Medtronic in Q4 2016 and has held it in 26 quarters since.
  • Mascoma Wealth Management's Medtronic position peaked at $67K in Q1 2017.
  • 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Mascoma Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.